Aryl alkenoic acid derivatives as leukotriene antagonists
    1.
    发明授权
    Aryl alkenoic acid derivatives as leukotriene antagonists 失效
    芳基烯酸衍生物作为白三烯拮抗剂

    公开(公告)号:US5266713A

    公开(公告)日:1993-11-30

    申请号:US928693

    申请日:1992-08-12

    摘要: Aryl alkenoic acid derivatives, and physiologically acceptable salts thereof, are provided which are potent leukotriene antagonists and may be used for the treatment of circulatory diseases and preferably for respiratory diseases such as asthma. The derivatives have a general formula I ##STR1## in which X is --S--,W is CH.dbd.CH;o is 1 to 4;n is 2 to 6;m is 0 to 2;T and Z, same or different, represent oxygen or a direct bond;R.sup.2 and R.sup.3, represent hydrogen, or fluorine;A represents carboxyl, CO.sub.2 R.sub.4.sup.4, wherein R.sup.4 is lower alkylR is ##STR2## wherein Y represents carboxyl, CO.sub.2 R.sup.4, wherein R.sup.4 is lower alkylR.sup.7 and R.sup.8, same or different, represent H or lower alkyl;R.sup.9 represents --OH, --O-alkyl, NH.sub.2 or a NHCH.sub.2 CO.sub.2 H group; andR.sup.10 R3 is H.

    摘要翻译: 提供了芳基链烯酸衍生物及其生理上可接受的盐,它们是有效的白三烯拮抗剂,可用于治疗循环系统疾病,优选用于呼吸系统疾病如哮喘。 衍生物具有通式I(I)其中X是-S-,W是CH = CH; o是1到4; n为2〜6; m为0〜2; T和Z相同或不同,代表氧或直接键; R2和R3代表氢或氟; A表示羧基,CO 2 R 44,其中R 4是低级烷基R 3是其中Y表示羧基,CO 2 R 4,其中R 4是低级烷基,R 7和R 8相同或不同,表示H或低级烷基; R9表示-OH,-O-烷基,NH2或NHCH2CO2H基团; R10 R3为H.

    Tetrahydro-Quinolinylurea Derivatives
    3.
    发明申请
    Tetrahydro-Quinolinylurea Derivatives 审中-公开
    四氢喹啉基脲衍生物

    公开(公告)号:US20100137361A1

    公开(公告)日:2010-06-03

    申请号:US12700417

    申请日:2010-02-04

    IPC分类号: A61K31/47 A61P11/06 A61P13/02

    CPC分类号: C07D215/38

    摘要: This invention relates to tetrahydro-quinolinylurea derivatives and salts thereof which are useful as active ingredients of pharmaceutical preparations.The tetrahydro-quinolinylurea derivative of the present invention has vanilloid receptor (VR1) antagonistic activity, and can be used for the prophylaxis and treatment of diseases associated with VR1 activity, in particular for the treatment of urological diseases or disorders, such as detrusor overactivity (overactive bladder), urinary incontinence, neurogenic detrusor overactivity (detrusor hyperflexia), idiopathic detrusor overactivity (detrusor instability), benign prostatic hyperplasia, and lower urinary tract symptoms; chronic pain, neuropathic pain, postoperative pain, rheumatoid arthritic pain, neuralgia, neuropathies, algesia, nerve injury, ischaemia, neurodegeneration, stroke, and inflammatory disorders such as asthma and chronic obstructive pulmonary (or airways) disease (COPD).

    摘要翻译: 本发明涉及可用作药物制剂活性成分的四氢 - 喹啉基脲衍生物及其盐。 本发明的四氢 - 喹啉基脲衍生物具有香草素受体(VR1)拮抗活性,可用于预防和治疗与VR1活性有关的疾病,特别是用于治疗泌尿系统疾病或障碍,例如逼尿肌过度活动 膀胱过度活动),尿失禁,神经源性逼尿肌过度活动(逼尿肌hyperflexia),特发性逼尿肌过度活动(逼尿肌不稳定),良性前列腺增生和下尿路症状; 慢性疼痛,神经性疼痛,术后疼痛,类风湿性关节炎疼痛,神经痛,神经病,痛觉,神经损伤,局部缺血,神经变性,中风和炎性疾病如哮喘和慢性阻塞性肺(或气道)疾病(COPD)。